The objective of this study was to investigate the contribution of left ventricular (LV) diastolic dysfunction to weaning failure, along with the levels of the currently used cardiac biomarkers. Forty-two mechanically ventilated patients, who fulfilled criteria for weaning from mechanical ventilation (MV), underwent a two-hour spontaneous breathing trial (SBT). Transthoracic echocardiography (TTE) was performed before the start of the SBT. The grade of LV diastolic dysfunction was assessed by pulsed-wave Doppler and tissue Doppler imaging at the level of the mitral valve. Haemodynamic and respiratory parameters were recorded. Blood levels of B-type natriuretic peptide (BNP), troponin I, creatine kinase-MB, and myoglobin were measured on MV and at the end of the SBT. Weaning success was defined as the patient's ability to tolerate spontaneous breathing for more than 48 hours. Fifteen patients failed to wean. LV diastolic dysfunction was significantly associated with weaning failure (P <0.001). The grade of diastolic dysfunction was significantly correlated with BNP levels both on MV and at the end of the SBT (P <0.001, r = 0.703 and P <0.001, r = 0.709, respectively). BNP levels on MV were lower in patients who successfully weaned compared to those who did not (361 ± 523 ng/l versus 643 ± 382 ng/l respectively, P=0.008). The presence of diastolic dysfunction was independently associated with weaning failure (odds ratio [OR] 11.23, confidence interval [CI] 1.16-109.1, P=0.037) followed by respiratory frequency/tidal volume (OR 1.05, CI 1.00-1.10, P=0.048). Therefore, assessment of LV diastolic function before the start of weaning could be useful to identify patients at risk of weaning failure.
Cardiac dysfunction during weaning from mechanical ventilation (MV) has been recognised as a likely contributing factor to weaning failure 1 . Pulmonary artery catheterisation has been used to detect the differential haemodynamic changes during the transition from mechanical ventilation to spontaneous breathing [1] [2] [3] , mainly in patients with difficult weaning, which affects 30%-40% of critically ill patients undergoing MV 4 .
Over the past decade, due to lack of evidence concerning the benefits of pulmonary artery monitoring 5 , the use of transthoracic echocardiography (TTE) has been increasingly recommended in order to non-invasively evaluate cardiac function at the bedside [6] [7] [8] . Accordingly, weaning-induced cardiovascular alterations have been studied [9] [10] [11] [12] [13] [14] [15] . Specifically, a number of studies have focused on the evaluation of left ventricular (LV) diastolic dysfunction before and during weaning trials from MV. Critically ill patients with pre-existing heart failure 14 ; patients with preserved LV systolic function 11 ; difficult-to-wean 13 , as well as successfully weaned, patients 15 ; and unselected ICU patients 12 have been included in these studies exposing the importance of LV diastolic dysfunction in the evolution of weaning, previously largely underdiagnosed 9 .
Additionally, biochemical indices of the volume status and functional state of the heart, such as natriuretic peptide levels, have been used to identify patients who fail to wean. High basal levels of natriuretic peptides and/or an increase during the weaning process have been associated with an increased risk of weaning failure, indicating possibly underestimated cardiac dysfunction. However, their ability to predict the weaning outcome has not yet been fully confirmed [15] [16] [17] [18] [19] [20] .
Data combining the diagnostic performance of both TTE variables and biochemical markers in the weaning process are limited. The few available studies have focused on patients with chronic obstructive pulmonary disease (COPD) 17 as well as on successfully weaned patients 15 ; only one recent study has included a diverse patient population 18 . The aim of the present study was to estimate the contribution of LV diastolic dysfunction to weaning failure, along with simultaneous evaluation of currently used biomarkers of cardiac function.
Methods

Patients
This prospective study was conducted in the ICU1, a 12-bed section of the multidisciplinary 25-bed ICU of Evangelismos Hospital, a tertiary medical centre, from December 2010 to June 2011. The study was approved by the Hospital Ethics Committee (20/10/2010, No. 357) . Because it was a descriptive study the need for written informed consent was waived. All patients who participated in the study or their next of kin gave verbal informed consent before entering the study.
All patients of the ICU1 who were intubated and mechanically ventilated for more than 48 hours during the study period were considered eligible for the study. Inclusion criteria were (a) the underlying cause of acute respiratory failure had improved and the attending physician considered the patient ready to undergo a spontaneous breathing trial (SBT) on the basis of readiness-to-wean criteria used in our unit, similar to those proposed elsewhere 4 ; (b) the presence of a central venous and a peripheral arterial catheter. Exclusion criteria were age <18 years, pregnancy, ICU re-admission, ineligibility for echocardiographic study (poor echocardiographic window, heart rate over 110 beats per minute, non-sinus rhythm). Atrioventricular conduction abnormalities, paced rhythm, and significant valvulopathies were also excluded because they can affect the Doppler parameters 21 .
Demographic and clinical characteristics and laboratory values were recorded. The illness severity was evaluated by the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Sequential Organ Failure Assessment (SOFA) scoring systems 22, 23 , calculated on the first day of ICU admission. Fluid balance in the 48 hours prior to the SBT was recorded.
Measurements
Respiratory parameters: During MV, before the SBT, respiratory frequency (f), tidal volume (V T ), minute ventilation (V E ), level of positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO 2 ), peak airway pressure (Ppeak), and mean airway pressure (Pmean) were recorded. Dynamic compliance (Cdyn) of the respiratory system was calculated as V T divided by Ppeak minus PEEP 24 . During temporary disconnection from the ventilator, maximum inspiratory pressure (MIP) was measured as the maximal negative excursion in airway pressure during a 20-second occlusion using a one-way valve 25 . During the SBT, V E was measured with a calibrated handheld Wright's spirometer (nSpire Health Ltd, UK) through the endotracheal tube. The average V T was obtained by dividing V E by the f. The ratio of f to V T was then calculated 24 .
Haemodynamic and gas exchange parameters: Invasive systemic arterial blood pressure, heart rate and central venous pressure (CVP) were continuously monitored. Partial pressures of oxygen (PaO 2 ) and carbon dioxide (PaCO 2 ), pH, and haemoglobin oxygen saturation (SaO 2 ) were determined from blood samples drawn from the arterial line and immediately analysed; central venous haemoglobin oxygen saturation (ScvO 2 ) was measured from blood samples drawn from the internal jugular or subclavian line (ABL 700; Radiometer Medical Aps, Brønshøj, Denmark).
Cardiac biomarkers
Cardiac biomarkers including B-type natriuretic peptide (BNP), cardiac troponin-I (cTnI), creatine kinase (CK)-MB and myoglobin were measured in blood using a rapid fluorescence immunoassay (Alere Triage® MeterPro, Biosite Inc., San Diego, CA, USA). The measurable ranges were for BNP 5-5000 ng/l, cTnI 0.05-30 µg/l, CK-MB 1.0-80 µg/l and myoglobin 0.28-28 nmo/l. The normal values of these biomarkers are less than 100 ng/l, 0.4 µg/l, 4.3 µg/l and 6.1 nmol/l respectively.
TTE examination
Two-dimensional TTE examination was performed during assisted controlled MV, before the SBT, using a Vivid 7 (General Electric Healthcare, Amersham, UK) 26, 27 . Conventional examination was performed to assess LV systolic function, structural abnormalities and internal dimensions. Left ventricular ejection fraction (LVEF) was estimated using the Simpson's modified method of disks. Systolic dysfunction was defined by an LVEF <50% or the presence of wall motion abnormalities. Doppler echocardiography was performed from the apical 4-chamber view with the referred-to ultrasound device equipped with the tissue Doppler imaging program. Doppler signals were recorded along with the electrocardiogram and respiratory cycle waveform. Measurements were performed at endexpiration, in order to minimise the confounding effect of positive intrathoracic pressure on cardiac function and to obtain all measurements at the same time of the respiratory cycle. The average of three end-expiratory cycles was used. Transmitral flow velocities (peak early diastolic E and peak late diastolic A) were recorded with pulsed-wave Doppler, placing the sample volume at the mitral valve tips from the apical 4-chamber view; deceleration time of the E wave (DTE) was measured. Peak early diastolic (e') velocity was obtained with tissue Doppler imaging (TDI), in the apical 4-chamber view, positioning the pulsed-wave Doppler sample volume at or 1 cm within the septal insertion sites of the mitral leaflets, so as to cover the longitudinal excursion of the mitral annulus in both systole and diastole. Then, the E/A ratio and the transmitral inflow E wave to mitral annular e' (E/e') were calculated. The LV diastolic dysfunction was graded according to the American Society of Echocardiography recommendations 27 . Patients were classified as having i) normal diastolic function, ii) grade I (mild) diastolic dysfunction (impaired relaxation pattern), or iii) grade II to III (moderate to severe) diastolic dysfunction (pseudonormal or restrictive filling pattern, respectively). All the echocardiographic examinations were performed by two cardiologists (AT and IK), not involved in the weaning process.
Study Protocol
All patients were mechanically ventilated in the assisted controlled mode (Maquet Servo I ventilator, Maquet, Sweden). Subsequently, they underwent a two-hour SBT through a T-piece circuit with the same level of fractional inspired oxygen concentration (FiO 2 ) used during MV. Oxygen saturation (SpO 2 ) was continuously monitored. Systemic blood pressure, heart rate, CVP, arterial and central venous blood gas and respiratory parameters were recorded at baseline (immediately before disconnection from the ventilator). Blood levels of BNP, cTnI, CK-MB and myoglobin were measured at baseline and at the end of SBT. V E and f were also measured at two minutes after the start of the SBT.
SBTs lasted for two hours unless patients met criteria used to define SBT failure 28 : tachypnoea (f greater than 35 breaths per minute), SpO 2 of less than 85% to 90%, tachycardia (heart rate greater than 120 to 140 beats per minute) or a sustained change in heart rate of more than 20%, systolic arterial blood pressure greater than 180 to 200 mmHg or less than 90 mmHg, arrhythmias, increased accessory muscle use, diaphoresis, and onset or worsening of discomfort. The ability of the patient to sustain spontaneous breathing for two hours was defined as a successful SBT and the patient was extubated. Patients who met criteria of weaning failure before the end of the two-hour SBT were reconnected to the ventilator. In this case all measurements were performed just before reconnecting the patient to the ventilator.
Weaning success was defined as the patient's ability to tolerate spontaneous breathing for more than 48 hours after extubation. Weaning failure was defined as SBT failure or reintubation in the following 48 hours after extubation 4 . The decision for extubation or reinstitution of MV was taken by the attending physicians, who were blinded to echocardiographic and blood results, although arterial blood gas values and routine respiratory measurements were available to them.
Statistical analysis
Continuous variables are expressed as mean ± SD and categorical variables as percentages. Comparisons between groups were made with Student's t-test or Mann-Whitney U test for parametric and non-parametric variables, respectively. Categorical variables were compared with the chi-square test. Correlations between variables were identified appropriately using the Pearson's or Spearman's test. Between-group differences for BNP at MV and SBT were analysed with analysis of variance (ANOVA) 2×2 (time × group) repeated measures. The differences in baseline BNP values among different grades of diastolic function were assessed with the Kruskal-Wallis test. Mann-Whitney tests, as post hoc analyses, were also employed after correction of significance level to consider the number of between-group comparisons. In identifying the independent risk factors for weaning failure, multiple logistic regression analysis was performed. A P value <0.05 was considered statistically significant. All analyses were performed using SPSS for Windows, version 13 (SPSS Inc., Chicago, IL, USA).
Results
During the study period, 102 patients were considered for inclusion in the study. Of these patients, 60 were excluded. On the study day, 35 patients tolerated the SBT and were extubated whereas seven patients met the criteria for weaning failure after 76 ± 52 minutes and required the reinstitution of MV. Eight patients required reintubation in the 48 hours following extubation; thus, 27 patients were successfully weaned and 15 patients failed ( Figure 1 ).
Patient characteristics and weaning outcome
Demographic and clinical characteristics of the patients are shown in Table 1 . Patients who failed were older, with more cardiac comorbidities, higher positive fluid balance during the two days preceding the SBT, and higher ICU mortality.
Respiratory, gas exchange, and haemodynamic parameters and cardiac biomarkers at baseline are shown in Table 2 . On MV, compared to those successfully weaned, patients who failed had significantly lower values of MIP, V T and Cdyn, whereas Pmean and CVP were significantly higher. There were no significant differences in gas exchange parameters between weaning failure and success with the exception of ScvO 2 (70.4% ± 8.7 versus 77.1% ± 6.7, respectively, P=0.01).
The f/V T at the second minute after disconnection from the ventilator was significantly higher in failed-to-wean patients (102 ± 55 versus 62 ± 23 breaths/min/l, P=0.016). Baseline BNP levels were significantly higher in patients who failed than in those who succeeded (643 ± 382 ng/l versus 361 ± 523 ng/l, P=0.008), whereas cTnI and CK-MB values were barely higher (P=0.069 and 0.075, respectively) ( Table 2) . At the end of the SBT, CK-MB values were significantly higher in patients who failed the SBT, compared to those who succeeded (8.77 ± 20.5 versus 1.52 ± 1.42 µg/l, P=0.047). Compared to baseline, the BNP levels increased at the end of the SBT in failed patients, however not significantly. The difference in BNP increase was significantly higher in the weaning failure compared to the success group (102 ± 184 ng/l versus -46 ± 243 ng/l, respectively, P=0.047) ( Figure 2) . cTnI, CK-MB and myoglobin blood levels did not change significantly at the end of the SBT.
Echocardiography
Echocardiographic data were not available for analysis in eight patients for technical reasons (incomplete data). Out of the 34 patients with a complete TTE study, 22 succeeded and 12 failed to wean. No statistically significant differences were observed in the Doppler echocardiographic variables (E, A, E/A, septal e', septal E/e') between the weaning success and failure patients at baseline (Table 3) . LVEF <50% was present in seven patients; it was not related to weaning failure (P=0.21, Table 3 ).
Normal diastolic function was observed in 13 (38%) patients whereas LV diastolic dysfunction of grade 1, 2 and 3 was observed in 12 (35%), five (15%) and four (12%) patients, respectively. LV diastolic dysfunction was significantly associated with weaning failure (P <0.001) (Table 4, Figure  3 ). Patients with diastolic dysfunction compared to those without, were older; they frequently presented a history of hypertension, coronary artery disease and atrial fibrillation. BNP levels, cTnI and myoglobin were significantly higher in patients with LV diastolic dysfunction compared to those without. The grade of diastolic dysfunction was significantly correlated with BNP levels both on MV and at the end of the SBT (P <0.001, r 0.703 and P <0.001, r 0.709, respectively). Figure 4 depicts the baseline BNP levels according to grade of diastolic dysfunction.
By multiple logistic regression analysis incorporating f/V T at the second minute of SBT, presence of diastolic function, BNP, and fluid balance in the 48 hours prior to SBT, the best independent risk factor for weaning failure was the presence of diastolic dysfunction (OR 11.23; CI 1.16-109.1, P=0.037), followed by f/V T (OR 1.05; CI 1.00-1.10, P=0.048), Table 5 .
Discussion
The principal findings of our study are that in a general ICU Figure 2 : B-type natriuretic peptide (BNP) blood levels on mechanical ventilation (MV) and at the end of spontaneous breathing trial (SBT) in patients with successful and those with failed SBT. The difference in BNP value increase was significantly higher in the weaning failure compared to the success group, P=0.047. patient population undergoing an SBT for weaning from MV, (i) LV diastolic dysfunction was an independent risk factor for weaning failure; (ii) during SBT, the BNP levels increased significantly more in patients who failed to wean; (iii) there was a significant correlation between grades of diastolic dysfunction and BNP levels at baseline. The association of LV diastolic dysfunction with weaning outcome found in the present study is in accordance with the findings of previous studies addressing the role of LV diastolic dysfunction in weaning failure [10] [11] [12] [13] . In a mechanically ventilated ICU patient population with preserved LV systolic function, Papanicolaou et al 11 have shown that the degree of LV diastolic dysfunction was associated with weaning failure. The present study, evaluating an unselected ICU patient population, has shown similar results. Since only seven patients with systolic impairment (LVEF <50%) participated in the present study, our patient population could be considered analogous. Approximately 62% of our patients had LV diastolic dysfunction of some grade, which is similar to the 56% found by Papanicolaou et al, indicating the high prevalence of this largely otherwise underdiagnosed condition. On MV, before the SBT, we did not find significant differences in tissue Doppler echocardiography variables alone, between patients who succeeded and those who failed to wean. This is in accordance with findings by Lamia et al 13 , who did not find significant differences in any of these variables, at baseline, between difficult-to-wean patients who developed weaning-induced pulmonary artery occlusion pressure elevation and failed, and those who did not. Similarly, in the study by Caille and colleagues 12 , E/A ratio before the SBT was not a discriminating parameter for weaning outcome, whereas DTE shortening, indicating diastolic dysfunction, was barely lower in the case of weaning failure. In that study, statistically significant higher E/e' in patients who failed as compared to those who were successfully weaned was observed. Indeed, E/e' is thought to be a better echocardiographic index than E/A to detect an increase in LV filling pressure, at least in patients with systolic heart failure 14 . To note, the majority of patients included in the above-mentioned study 12 presented systolic dysfunction (LVEF <50%), an important factor that can affect the LV filling pressures and E/e'. In our study there was a trend for higher E/e' in patients failing to wean but it did not reach statistical significance. The fact that our study population included a low proportion of patients with systolic dysfunction (7/34, 18%), similar to that of 20% in the study by Lamia et al 13 , could explain, at least in part, this differentiation and indicates the importance of patient selection on the results. Similar findings were reported by Mochietto and colleagues 10 ; although patients who failed had a significantly higher basal E/e', the ability of predicting weaning failure by this variable did not have an acceptable diagnostic power. Age-related changes in the heart impact diastolic function. In the present study failed-to-wean patients were significantly older, suggesting frequent diastolic filling abnormalities. Indeed, age was found to be positively correlated with the presence of diastolic dysfunction (r 0.67, P <0.001, Spearman).
Cardiac biomarkers
The relative merits of natriuretic peptide measurement in mechanically ventilated patients undergoing weaning from MV have not yet been clarified [14] [15] [16] [17] [18] [19] [20] . We found that the increase in BNP levels was significantly higher at the end of the SBT in patients who failed compared to those who succeeded. Also, interestingly, baseline BNP levels were higher in patients who failed than in patients who succeeded, providing a possible usefulness in weaning outcome prediction. However, multivariable analysis did not identify the BNP level before the SBT as an independent risk factor for weaning failure. This finding is in accordance with that reported by Grasso and colleagues 17 ; although NT (N terminal fragment)-proBNP values increased during the weaning trial in difficult-to-wean COPD patients, the diagnostic performance of baseline values was poor. Similarly, Lamia et al have shown that a NT-proBNP level measured before the SBT did not predict the outcome of SBT; however, it was the only independent predictor of post-extubation respiratory distress 29 . Conversely, other studies demonstrated higher baseline plasma BNP levels in patients with subsequent weaning failure 16, 18 , or variable changes 15 , depending on the underlying cardiac function.
There are relatively few reports combining BNP and echocardiographic variables in mechanically ventilated patients 15, 17, 18 . To our knowledge, the present study is the first to demonstrate a relation between BNP levels and the grade of diastolic dysfunction, suggesting that BNP is a surrogate marker of increased LV filling pressure in mechanically ventilated patients, as has been previously demonstrated in heart failure patients [30] [31] . In addition, this finding could provide an explanation, at least in part, for why an elevated BNP value predicts weaning failure in the absence of LV systolic function estimation.
In the present study, prior to SBT, cTnI values were barely higher in patients who failed. However, when patients were divided according to the presence of diastolic dysfunction, cTnI along with BNP and myoglobin were significantly higher in patients with diastolic dysfunction, confirming their role as cardiac biomarkers.
There are certain limitations to our study. Firstly, the relatively small number of patients studied probably limits the generalisability of our findings and indicates the need for further confirmation. However, it should be noted that in some relevant studies [13] [14] [15] 19 , or in other publications on weaning pathophysiology 1-3 , similar numbers of patients have been included. Secondly, we had included a heterogenous cohort of patients with both medical and surgical type of critically ill patients requiring MV for a variety of different reasons; however, this population is representative of that usually admitted in a multidisciplinary ICU.
In conclusion, LV diastolic dysfunction assessed by TTE was independently associated with weaning failure. Based on these findings and on those previously published, it could be suggested that assessment of LV diastolic function before attempting a weaning process, could be useful in the detection of patients likely to fail weaning. In combination with cardiac biomarkers, especially the BNP level, it could complement the clinical information in the complex setting of weaning failure. 
